Table 3 Visual analysis of synthesis process
From: Design, synthesis, and preliminary biological evaluation of catalpol propionates as antiaging drugs
No. | A | B | C | D | Yield (%) |
|---|---|---|---|---|---|
1 | 1 | 1 | 1 | 1 | 4.47 |
2 | 1 | 2 | 2 | 2 | 12.66 |
3 | 1 | 3 | 3 | 3 | 11.45 |
4 | 2 | 1 | 2 | 3 | 26.31 |
5 | 2 | 2 | 3 | 1 | 39.82 |
6 | 2 | 3 | 1 | 2 | 30.06 |
7 | 3 | 1 | 3 | 2 | 68.82 |
8 | 3 | 2 | 1 | 3 | 60.11 |
9 | 3 | 3 | 2 | 1 | 64.91 |
K1 | 9.527 | 33.200 | 31.547 | 36.400 | Â |
K2 | 32.063 | 37.530 | 34.627 | 37.180 | Â |
K3 | 64.613 | 35.473 | 40.030 | 32.623 | Â |
R | 55.086 | 4.330 | 8.483 | 4.557 | Â |